We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

MINDRAY In-Vitro Diagnostics

As a global leader in in-vitro diagnostics, Mindray provides a wide range of efficient, reliable IVD solutions for la... read more Featured Products: More products

Download Mobile App




Mindray Takes Home 288 IVDR CE Certificates to Cover All IVD Product Segments

By LabMedica International staff writers
Posted on 03 Sep 2022
Print article
Image: Mindray recently obtained CE Certificate issued by TÜV SÜD (Photo courtesy of Mindray)
Image: Mindray recently obtained CE Certificate issued by TÜV SÜD (Photo courtesy of Mindray)

Mindray (Shenzhen, China) has obtained a CE Certificate issued by TÜV SÜD, a notified body designated under the EU's IVDR, bringing the total number of IVDR-certified products to 288 in the company’s IVD portfolio, covering hematology, biochemistry, immunoassay, specific proteins, HbA1c, among others.

CE certification is a pass for products to enter the EU market and circulate freely throughout the EU. It represents that the products comply with the relevant EU laws, regulations and standards. IVDR is short for the Regulation (EU) 2017/746 of the European Parliament and of the Council of 5 April 2017 on in-vitro diagnostics medical devices and repealing Directive 98/79/EC and Commission Decision 2010/227/EU. After the transitional period for the implementation of the IVDR, IVD medical devices that have not obtained IVDR CE certification will be denied access to the EU market. The newly launched IVDR EU 2017/746 aims to establish a modern and stricter regulatory framework to better protect the health and safety of the public and patients. Therefore, compared to the IVDD, the IVDR places more emphasis on the life-cycle management and continuous evaluation of products. The IVDR requires manufacturers to show that they have an effective quality management system (QMS) in place to ensure product safety, effectiveness, and post-market surveillance.

Mindray's CE-certified products include hematology analyzers and quality controls/calibrators, HbA1c analyzers, integrated CRP analyzers along with reagents and quality controls/calibrators, etc. After Mindray's β2-MG chemistry reagent obtained the first IVDR certification in China, all Mindray's internationally marketable chemistry analyzers, as well as their reagents, consumables, calibrators, and quality controls, have followed suit. Mindray's certified chemiluminescence immunoassay products now cover tumor markers, thyroid functions, reproductive hormones, adrenal hormones, myocardium, anemia and bone metabolism, liver fibrosis, inflammation, diabetes, hypertension, ToRCH, and other fields of testing. In addition, Mindray has completed relevant marketing procedures for the newly launched products this year.

Mindray's success in being one of China’s first recipients of the IVDR CE certification relies heavily on its sound and effective quality management system (QMS). Mindray has been placing top priority on quality, providing stable and safe medical equipment for customers from across the globe. In addition, the company has implemented stringent clinical trial and data control processes, which ensure the continuous optimization of management duties, design control, production control, error correction and prevention, post-market surveillance, and other modules. With its guaranteed quality and excellent services, Mindray’s IVD products and solutions have been installed in several top-tier hospitals and laboratories across Europe.

The EU is a key target market for Mindray IVD to expand overseas. All Mindray's internationally marketable products have obtained IVDR certification, which reflects the recognition of the notified body of their quality, safety and effectiveness, as well as their ability to meet the regulations and standards in various regions worldwide. This will help Mindray to expand in the global market and further consolidate its IVD’s presence in Europe. Going forward, Mindray aims to continue providing high quality products and solutions through independent R&D and innovation efforts and a robust QMS.

Related Links:
Mindray 

New
Platinum Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Hemoglobin Testing System
VARIANTnbs

Print article

Channels

Clinical Chemistry

view channel
Image: The new ADLM guidance will help healthcare professionals navigate respiratory virus testing in a post-COVID world (Photo courtesy of 123RF)

New ADLM Guidance Provides Expert Recommendations on Clinical Testing For Respiratory Viral Infections

Respiratory tract infections, predominantly caused by viral pathogens, are a common reason for healthcare visits. Accurate and swift diagnosis of these infections is essential for optimal patient management.... Read more

Molecular Diagnostics

view channel
Image: The HelioLiver Dx test has met the coprimary and secondary study endpoints in the CLiMB trial (Photo courtesy of Helio Genomics)

Blood-Based Test Outperforms Ultrasound in Early Liver Cancer Detection

Patients with liver cirrhosis and chronic hepatitis B are at a higher risk for developing hepatocellular carcinoma (HCC), the most prevalent type of liver cancer. The American Association for the Study... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Microbiology

view channel
Image: The POC PCR test shortens time for STI test results (Photo courtesy of Visby Medical)

POC STI Test Shortens Time from ED Arrival to Test Results

In a 2024 sexually transmitted infections (STIs) surveillance report by the World Health Organization (WHO), over 2.5 million cases were recorded, alongside a rise in the inappropriate use of antibiotics... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.